157 results on '"Singh, Itu"'
Search Results
2. Genomic characterization of Mycobacterium lepromatosis from ENL patients from India
3. High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen
4. Diagnostic Utility of Multiplex Polymerase Chain Reaction in Patients of Clinically Suspected Pure Neuritic Leprosy by Identifying Mycobacterium leprae in Skin Biopsy Samples and Nasal Swabs.
5. Morphological Index as a Sensitive Marker of Drug Resistance in Leprosy: A Case Series
6. Neuroimaging in leprosy: the nerves and beyond
7. Assessment of Clinical, Histopathological, and Bacteriological Findings in Treated Leprosy Patients with Persistent Skin Lesions: A Retrospective Cohort Study
8. Unveiling the clinical and epidemiological significance of Mycobacterium lepromatosis detection in a patient with severe lepra reaction from India.
9. Mimicking B and T cell epitopes between Mycobacterium leprae and host as predictive biomarkers in type 1 reaction in leprosy
10. Utility of multiplex PCR for early diagnosis and household contact surveillance for leprosy
11. Time to revisit the purported link of leprosy reactions with infective triggers: An unnecessary economic burden for patients.
12. Case Report: An Atypical Case of Post-Kala-Azar Dermal Leishmaniasis with Ulcers and Verrucous Lesions: Clinical and Therapeutic Implications
13. Authors’ reply
14. Effective amelioration of the Lucio phenomenon with adjuvant tofacitinib therapy in a patient with dual infection of Mycobacterium leprae and Mycobacterium lepromatosis: a case report from India
15. Effective amelioration of lucio phenomenon with adjuvant tofacitinib therapy in a patient with dual infection of M. leprae and M. lepromatosis: A case report from India.
16. Type 2 reaction associated sensorineural hearing loss in a drug resistant lepromatous leprosy patient: A case report
17. Case Report: An Atypical Case of Post-Kala-Azar Dermal Leishmaniasis with Ulcers and Verrucous Lesions: Clinical and Therapeutic Implications.
18. Editorial: Modern molecular era of the mycobacterial world: Insights into diagnosis and transmission of mycobacteria and associated diseases
19. High frequency of ofloxacin resistance patterns of Mycobacterium lepraefrom India: An indication to revisit second line anti-leprosy treatment regimen
20. Diagnosis of Leprosy: Current Updates and Future Directions
21. Molecular mimicry between Mycobacterium leprae proteins (50S ribosomal protein L2 and Lysyl-tRNA synthetase) and myelin basic protein: a possible mechanism of nerve damage in leprosy
22. Comparative evaluation of PCR amplification of RLEP, 16S rRNA, rpoT and Sod A gene targets for detection of M. leprae DNA from clinical and environmental samples
23. Corroboration of cross-reactivity between Mycobacterium leprae and hosts’ salivary and cutaneous proteins: A hope for prognostic biomarkers for the pathogenesis of reactions in leprosy
24. A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions
25. Efficacy of fixed duration multidrug therapy for the treatment of multibacillary leprosy: A prospective observational study from Northern India
26. Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases
27. Existence of viable Mycobacterium leprae in natural environment and its genetic profiling in a leprosy endemic region
28. Effective amelioration of lucio phenomenon with adjuvant tofacitinib therapy in a patient with dual infection of M. leprae and M. lepromatosis : A case report from India.
29. A report of rifampin-resistant leprosy from northern and eastern India: identification and in silico analysis of molecular interactions
30. High prevalence of resistance to anti-leprosy drugs in leprosy cases with chronic erythema nodosum leprosum: A matter of concern
31. Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India
32. Drug resistance to rifampicin in a case of steroid‐dependent erythema nodosum leprosum and the therapeutic implications of resistance and reactions in leprosy
33. Detection of Mycobacterium lepromatosis in patients with leprosy in India
34. Drug resistance in Mycobacterium Leprae in the context of zero leprosy
35. Appropriately Selected Nerve in Suspected Leprous Neuropathy Yields High Positive Results for Mycobacterium leprae DNA by Polymerase Chain Reaction Method
36. Evidence for Mycobacterium leprae Drug Resistance in a Large Cohort of Leprous Neuropathy Patients from India
37. A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions.
38. Successful treatment of rifampicin resistant case of leprosy by WHO recommended ofloxacin and minocycline regimen
39. Drug resistance in Mycobacterium Leprae in the context of zero leprosy.
40. Enriched whole genome sequencing identified compensatory mutations in the RNA polymerase gene of rifampicin-resistant Mycobacterium leprae strains
41. Association of non-tuberculous mycobacteria with Mycobacterium leprae in environment of leprosy endemic regions in India
42. Brain and Spinal Cord Lesions in Leprosy: A Magnetic Resonance Imaging–Based Study
43. Detection of Mycobacterium lepromatosis in patients with leprosy in India [Retraction]
44. VDR polymorphism, gene expression and vitamin D levels in leprosy patients from North Indian population
45. Paucibacillary Leprosy: Reappraisal using Ziehl-Neelsen staining of slit skin smears and 16S rRNA Real Time Polymerase Chain Reaction of nasal swabs
46. Autoimmunity to Tropomyosin-Specific Peptides Induced by Mycobacterium leprae in Leprosy Patients: Identification of Mimicking Proteins
47. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients
48. Detection of Mycobacterium gilvum first time from the bathing water of leprosy patient from Purulia, West Bengal
49. Mutation at codon 442 in the rpoB gene of Mycobacterium leprae does not confer resistance to rifampicin
50. Symposium on emerging needs in leprosy research in the post elimination era: The Leprosy Mission Trust India
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.